ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,996 | +121.9% | 2,648 | +168.3% | 0.00% | – |
| Q2 2023 | $13,068 | +108800.0% | 987 | +9.9% | 0.00% | – |
| Q1 2023 | $12 | +71.4% | 898 | +133.2% | 0.00% | – |
| Q4 2022 | $7 | -100.0% | 385 | -96.3% | 0.00% | -100.0% |
| Q3 2022 | $199,000 | +74.6% | 10,446 | +89.0% | 0.00% | 0.0% |
| Q2 2022 | $114,000 | -39.7% | 5,527 | -5.6% | 0.00% | +50.0% |
| Q1 2022 | $189,000 | +87.1% | 5,855 | +169.7% | 0.00% | 0.0% |
| Q4 2021 | $101,000 | +573.3% | 2,171 | +285.6% | 0.00% | – |
| Q3 2021 | $15,000 | -51.6% | 563 | -54.0% | 0.00% | -100.0% |
| Q2 2021 | $31,000 | -24.4% | 1,224 | +1.7% | 0.00% | 0.0% |
| Q1 2021 | $41,000 | +64.0% | 1,203 | +61.5% | 0.00% | 0.0% |
| Q4 2020 | $25,000 | -49.0% | 745 | -62.4% | 0.00% | 0.0% |
| Q3 2020 | $49,000 | – | 1,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |